Table 4

Complications, GVHD, and outcome*

ToxicityNo. of patients
Group AGroup BAll
Stomatitis    
    < 3rd degree 15 20 
    3rd or 4th degree 10 
Gastrointestinal tract    
    < 3rd degree 11 20 
    3rd or 4th degree 10 
Liver    
    < 3rd degree 16 
    3rd or 4th degree 14 
Kidney    
    < 3rd degree 12 12 24 
    3rd or 4th degree 
Lung    
    < 3rd degree 12 11 23 
    3rd or 4th degree 
Heart    
    < 3rd degree 12 15 27 
    3rd or 4th degree 
Acute GVHD    
    < grade 2 11 19 
    Grade 2 
    Grade 3 
    Grade 4 
Chronic GVHD (in evaluable patients)    
    None 11 18 
    Limited 
    Extended 
Rejection and relapse    
    Graft rejection 
    Relapse of disease 
Treatment-related mortality 
Dead 
Alive 14 23 
ToxicityNo. of patients
Group AGroup BAll
Stomatitis    
    < 3rd degree 15 20 
    3rd or 4th degree 10 
Gastrointestinal tract    
    < 3rd degree 11 20 
    3rd or 4th degree 10 
Liver    
    < 3rd degree 16 
    3rd or 4th degree 14 
Kidney    
    < 3rd degree 12 12 24 
    3rd or 4th degree 
Lung    
    < 3rd degree 12 11 23 
    3rd or 4th degree 
Heart    
    < 3rd degree 12 15 27 
    3rd or 4th degree 
Acute GVHD    
    < grade 2 11 19 
    Grade 2 
    Grade 3 
    Grade 4 
Chronic GVHD (in evaluable patients)    
    None 11 18 
    Limited 
    Extended 
Rejection and relapse    
    Graft rejection 
    Relapse of disease 
Treatment-related mortality 
Dead 
Alive 14 23 
*

Engraftment, toxicity, and GVHD were assessed by consensus criteria.36,37 

Two patients with preexisting liver disease developed fourth-degree toxicity of the liver; there were no other patients with fourth-degree toxicity of the liver.

No fourth-degree toxicity of the kidney was observed.

Close Modal

or Create an Account

Close Modal
Close Modal